Member of the European Academy of Sciences and Arts
Nima Rezaei mainly investigates Immunology, Primary immunodeficiency, Immune system, Disease and Common variable immunodeficiency. His is involved in several facets of Immunology study, as is seen by his studies on Hypogammaglobulinemia, Immunodeficiency, Cytokine, Proinflammatory cytokine and Virus. His work carried out in the field of Primary immunodeficiency brings together such families of science as Severe combined immunodeficiency, Recurrent infections, Pediatrics and Chronic granulomatous disease.
His Immune system research incorporates themes from Receptor, Pharmacotherapy and Pathogenesis. His study in Disease is interdisciplinary in nature, drawing from both Intensive care medicine and Virology. As a member of one scientific family, Nima Rezaei mostly works in the field of Common variable immunodeficiency, focusing on Bronchiectasis and, on occasion, Vaccination.
Nima Rezaei mostly deals with Immunology, Internal medicine, Disease, Immune system and Primary immunodeficiency. Nima Rezaei interconnects Single-nucleotide polymorphism, Genotype and Allele in the investigation of issues within Immunology. The various areas that Nima Rezaei examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology.
He has included themes like Receptor and Cancer research in his Immune system study. His Primary immunodeficiency study integrates concerns from other disciplines, such as Pediatrics and Immunodeficiency. Nima Rezaei combines subjects such as 2019-20 coronavirus outbreak and Severe acute respiratory syndrome coronavirus 2 with his study of Pandemic.
His main research concerns Coronavirus disease 2019, Immunology, Disease, Immune system and Severe acute respiratory syndrome coronavirus 2. His work on Pandemic as part of general Coronavirus disease 2019 study is frequently linked to In patient, therefore connecting diverse disciplines of science. Much of his study explores Immunology relationship to Cytokine storm.
His Disease study introduces a deeper knowledge of Internal medicine. His biological study spans a wide range of topics, including Inflammation and Cancer research. His Severe acute respiratory syndrome coronavirus 2 research is multidisciplinary, incorporating perspectives in Receptor and Outbreak.
Nima Rezaei mainly focuses on Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Coronavirus, 2019-20 coronavirus outbreak and Pandemic. His Coronavirus disease 2019 research is multidisciplinary, incorporating elements of CRISPR, Pathogenesis, MEDLINE and Virology. His Severe acute respiratory syndrome coronavirus 2 study combines topics from a wide range of disciplines, such as Respiratory tract, Receptor, Picotechnology and Action.
His Coronavirus research includes elements of Virus, Immune system, Antibody and Immunology. His Immunology study typically links adjacent topics like Cytokine storm. His Pandemic research incorporates elements of Pathological, Epidemiology, Intensive care medicine, Multiple sclerosis and Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017
Christina Fitzmaurice;Degu Abate;Naghmeh Abbasi;Hedayat Abbastabar.
JAMA Oncology (2019)
A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Erik-Oliver Glocker;Andre Hennigs;Mohammad Nabavi;Alejandro A. Schäffer.
The New England Journal of Medicine (2009)
HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)
Christoph Klein;Magda Grudzien;Giridharan Appaswamy;Manuela Germeshausen.
Nature Genetics (2007)
Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity
Gabriela Lopez-Herrera;Giacomo Tampella;Qiang Pan-Hammarström;Peer Herholz.
American Journal of Human Genetics (2012)
A Syndrome with Congenital Neutropenia and Mutations in G6PC3
Kaan Boztug;Giridharan Appaswamy;Angel Ashikov;Alejandro A. Schäffer.
The New England Journal of Medicine (2009)
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab;Sadaf G Sepanlou;Kevin Ikuta;Homayoon Vahedi.
The Lancet Gastroenterology & Hepatology (2020)
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Christopher J.L. Murray;Christopher J.L. Murray;Christopher J.L. Murray;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Peng Zheng;Peng Zheng;Peng Zheng;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati.
The Lancet (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos;Theo Vos;Theo Vos;Stephen S. Lim;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati;Kaja M. Abbas;Kaja M. Abbas;Kaja M. Abbas.
The Lancet (2020)
The phenotype of human STK4 deficiency
Hengameh Abdollahpour;Giridharan Appaswamy;Daniel Kotlarz;Daniel Kotlarz;Jana Diestelhorst;Jana Diestelhorst.
Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency
Vanessa Sancho-Shimizu;Rebeca Pérez de Diego;Lazaro Lorenzo;Rabih Halwani.
Journal of Clinical Investigation (2011)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: